Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hubing Shi

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|July 9, 2026
Cell-Interaction Analysis and Functional Studies Using Circulating Tumor Cell ModelsHubing Shi, Jinen Song
Methods in Molecular Biology (Clifton, N.J.)|November 22, 2013
Detecting mechanisms of acquired BRAF inhibitor resistance in melanomaRoger S Lo, Hubing Shi
Frontiers in Pharmacology|December 13, 2021
Pan-Cancer Analysis Reveals Alternative Splicing Characteristics Associated With Immune-Related Adverse Events Elicited by Checkpoint ImmunotherapyXiujing He, Jing Yu, Hubing Shi
Advances in Experimental Medicine and Biology|March 19, 2020
Mechanisms of Resistance to Checkpoint Blockade TherapyHubing Shi, Jiang Lan, Jiqiao Yang
Oncogene|October 7, 2020
Targeted degradation of immune checkpoint proteins: emerging strategies for cancer immunotherapyJie Xu, Jean-Philippe Brosseau, Hubing Shi
Cancer Research|August 2, 2011
Combinatorial treatments that overcome PDGFRβ-driven resistance of melanoma cells to V600EB-RAF inhibitionHubing Shi, Xiangju Kong, Antoni Ribas, et al.
Seminars in Cancer Biology|January 3, 2023
Artificial intelligence-based multi-omics analysis fuels cancer precision medicineXiujing He, Xiaowei Liu, Fengli Zuo, et al.
Frontiers in Pharmacology|July 18, 2019
Management of Adverse Events in Cancer Patients Treated With PD-1/PD-L1 Blockade: Focus on Asian PopulationsJiqiao Yang, Xiujing He, Qing Lv, et al.
Molecular Biomedicine|April 24, 2022
Omicron-included mutation-induced changes in epitopes of SARS-CoV-2 spike protein and effectiveness assessments of current antibodiesDu Guo, Huaichuan Duan, Yan Cheng, et al.
Blood|January 13, 2006
The angiogenic function of nucleolin is mediated by vascular endothelial growth factor and nonmuscle myosinYujie Huang, Hubing Shi, Hao Zhou, et al.
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Methods in Molecular Biology (Clifton, N.J.)|July 9, 2026
Cell-Interaction Analysis and Functional Studies Using Circulating Tumor Cell ModelsHubing Shi, Jinen Song
Methods in Molecular Biology (Clifton, N.J.)|November 22, 2013
Detecting mechanisms of acquired BRAF inhibitor resistance in melanomaRoger S Lo, Hubing Shi
Frontiers in Pharmacology|December 13, 2021
Pan-Cancer Analysis Reveals Alternative Splicing Characteristics Associated With Immune-Related Adverse Events Elicited by Checkpoint ImmunotherapyXiujing He, Jing Yu, Hubing Shi
Advances in Experimental Medicine and Biology|March 19, 2020
Mechanisms of Resistance to Checkpoint Blockade TherapyHubing Shi, Jiang Lan, Jiqiao Yang
Oncogene|October 7, 2020
Targeted degradation of immune checkpoint proteins: emerging strategies for cancer immunotherapyJie Xu, Jean-Philippe Brosseau, Hubing Shi
Cancer Research|August 2, 2011
Combinatorial treatments that overcome PDGFRβ-driven resistance of melanoma cells to V600EB-RAF inhibitionHubing Shi, Xiangju Kong, Antoni Ribas, et al.
Seminars in Cancer Biology|January 3, 2023
Artificial intelligence-based multi-omics analysis fuels cancer precision medicineXiujing He, Xiaowei Liu, Fengli Zuo, et al.
Frontiers in Pharmacology|July 18, 2019
Management of Adverse Events in Cancer Patients Treated With PD-1/PD-L1 Blockade: Focus on Asian PopulationsJiqiao Yang, Xiujing He, Qing Lv, et al.
Molecular Biomedicine|April 24, 2022
Omicron-included mutation-induced changes in epitopes of SARS-CoV-2 spike protein and effectiveness assessments of current antibodiesDu Guo, Huaichuan Duan, Yan Cheng, et al.
Blood|January 13, 2006
The angiogenic function of nucleolin is mediated by vascular endothelial growth factor and nonmuscle myosinYujie Huang, Hubing Shi, Hao Zhou, et al.
Pageof 9